Results 81 to 90 of about 16,213 (203)

Oral miltefosine for Indian visceral leishmaniasis. [PDF]

, 2002
BACKGROUND: There are 500,000 cases per year of visceral leishmaniasis, which occurs primarily in the Indian subcontinent. Almost all untreated patients die, and all the effective agents have been parenteral.
Berman, Jonathan, Thakur, C. P., Sundar, Shyam, Junge, Klaus, Thakur, CP, Bryceson, Anthony, Engel, Juergen, Sindermann, Herbert, Jha, TK, Jha, T. K., Fischer, Christina   +10 more
core   +1 more source

Antifungal activity of caspofungin in experimental infective endocarditis caused by Candida albicans

Memorias do Instituto Oswaldo Cruz
BACKGROUND Infective endocarditis is a disease characterised by heart valve lesions, which exhibit extracellular matrix proteins that act as a physical barrier to prevent the passage of antimicrobial agents.
Gerardo Becerra Victorio, Lorena Michele Brennan Bourdon, Leonel García Benavides, Selene G Huerta-Olvera, Arturo Plascencia, José Villanueva, Erika Martinez-Lopez, Iván Isidro Hernández-Cañaveral   +7 more
doaj   +1 more source

Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report

Journal of Microbiology and Infectious Diseases, 2016
In this paper, we present a 69 years old diabetic patient with mucormycosis who was succesfully treated with liposomal amphotericin B (LAMB), posaconazole and deferasirox despite having no adequate surgery.
Uğur Onal, Meltem Taşbakan, Tansu Yamazhan, Bilgin Arda, Husnu Pullukcu, Sercan Ulusoy, Oğuz Reşat Sipahi   +6 more
doaj   +1 more source

Use of liposomal amphotericin B in bone marrow transplant. [PDF]

, 2006
Increasing number of transplants worldwide has resulted in an increase in the incidence of fungal infections. Prolonged neutropenia, immunosuppression and graft vs. host disease all result in high predisposition to fungal infections.
Sastry P. S.R.K., Parikh PM, Kulkarni PS, Bhagwat R, Gadade H
core  

Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats [PDF]

, 2001
The effects of treatment with aerosolized amphotericin B desoxycholate and aerosolized liposomal amphotericin B were evaluated in severely immunosuppressed rats with invasive pulmonary aspergillosis.
Ruijgrok, E.J. (Elisabeth), Vulto, A.G. (Arnold), Etten, E.W.M. (Els) van   +2 more
core  

Immunological Effects of Amphotericin B Desoxycholate and Liposomal Amphotericin B on Splenocytes from Immune-Normal and Immune-Compromised Mice

, 1992
Because of the increasing number of serious risk factors which predispose a normally immune competent host to infection, the incidence of systemic fungal infections is steadily increasing.
Schindler, Jay Jenson
core   +1 more source

Use of liposomal amphotericin B in bone marrow transplant.

, 2005
Increasing number of transplants worldwide has resulted in an increase in the incidence of fungal infections. Prolonged neutropenia, immunosuppression and graft vs. host disease all result in high predisposition to fungal infections.
R. Bhagwat, H. Gadade, P. S. Kulkarni, P. M. Parikh, P. S. R. K. Sastry   +4 more
core   +1 more source

The direct costs of treating human visceral leishmaniasis in Brazil

Revista da Sociedade Brasileira de Medicina Tropical
INTRODUCTION: The drugs available for visceral leishmaniasis (VL) treatment in Brazil have specific characteristics in terms of operability, effectiveness, toxicity, and cost.
Tália Santana Machado de Assis, Dian Carlos Pinheiro Rosa, Eliane de Morais Teixeira, Gláucia Cota, André Luís Ferreira Azeredo-da-Silva, Guilherme Werneck, Ana Rabello   +6 more
doaj   +1 more source

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

Infection and Drug Resistance, 2012
Marisa H Miceli1, Pranatharthi Chandrasekar21Oakwood Hospital and Medical Center, Dearborn, 2Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, MI, USAAbstract: Liposomal amphotericin B is a "true&quot ...
Miceli MH, Chandrasekar P
doaj  

Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case

Revista da Sociedade Brasileira de Medicina Tropical
Visceral leishmaniasis is a systemic disease that is potentially severe and endemic in Brazil. It clinically manifests as fever, weight loss, swelling, hepatosplenomegaly, paleness, and edema.
Maria Antonia Ferreira Gomes, Lana Lira Cantidio de Medeiros, Fernanda Paula Dantas Lobo, Nathália Rayane Silva Wanderley, Ana Paula Rodrigues Matos, Tácito do Nascimento Jácome, Maria Goretti Lins Monteiro, Kleber Giovanni Luz   +7 more
doaj   +1 more source